NEW YORK, Aug. 20 – Paradigm Genetics has developed a microarray for the rice pathogen Magnaporthe grisea, the company said on Monday.

The chip, which was developed for Paradigm by Agilent Technologies, comprises a host of Magnaporthe gene sequences and positive and negative controls to help in data analysis, Paradigm said.

Data on the microarray will be incorporated into Paradigm’s existing database of fungal organisms, which may be used to help discover and develop products against fungi.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Gene drives might run into biological resistance, the Economist reports.

Forensic experts exhumed painter Salvador Dalí's body to collect DNA for a paternity test, CBS News reports.

Yale Environment 360 writes that synthetic and conservation biologists aren't always on the same wavelength, but they are trying to reach an understanding.

In Science this week: full CRISPR locus integration complex structure, and more.